Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
170,442Documents
1,450Full text
2026-09-28Last indexed
Recent documents from this source
- A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin#234390
- The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)#234389
- Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes#234388
- Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD#234387
- Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction#234386
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus#234385
- Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin#234384
- Can Gut Bacteria Predict Who Benefits Most From Exercise? A Gut Supplement to Help Exercise Non-Responders#234383
- Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.#234382
- The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus#234381
- Study of Erlotinib and Metformin in Triple Negative Breast Cancer#234380
- Role of Metformin on Muscle Health of Older Adults#234379
- The RCT of Acupuncture on PCOS Combined With IR#234378
- iGlarLixi CGM Study in Chinese T2D Individuals After OADs#234377
- PRF+1% MF for Class II Mandibular Furcation Defects#234376
- Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes#234375
- Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis#234374
- The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus#234373
- A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial#234372
- The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity#234371
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).